Continuing from the previous part, this article examines the place that divides recovery and annihilation. The cited references follow the original manuscript.
[Figure 5] The Operating Domain of β Suppression: The First Priority Is Not Medication but the Prevention of Accumulating Factors
| Priority | Category | Specific method | Operation | Effect |
|---|---|---|---|---|
| 1st priority | Prevention of accumulating factors | Exercise, diet, sleep, stress | Calming the DIAH trigger | Most effective |
| 2nd priority | Absorption-verified calcium intake | Maintaining blood concentration | Reducing bone-calcium outflow | Suppression possible |
| 3rd priority | Medication | Calcium channel blockers, etc. | Calming the surface figure | |
| Overall | β suppression alone | Blocking additional deposition | Buying time |
The fact that "defense" alone, which blocks microcalcification from piling up further, cannot achieve full recovery naturally leads us to the next stage, the domain of "removal (γ removal)." This is the process of directly breaking and eliminating the microcalcification that has already firmly embedded in the blood vessels. It is also a limit domain that existing modern medicine long dared not touch. But it is a place of hope where innovative technologies recently verified scientifically are entering, one after another, the clinical stage for the actual treatment of patients.
In the following article we will unravel this domain of "removal" in detail. We will examine what the three basic conditions for clearing away microcalcification in the blood vessels are, and how these technologies have already finished preparing to be applied to the actual medical field. Through this you will meet a new age in which true recovery does not remain mere vague theory but is realized as the reality of treating actual patients.
γ Removal: The Removal of Piled-Up Deposition
"Removal (γ removal)" is the process of directly eliminating the microcalcification that has already hardened onto the wall of the thin blood vessels. If "defense (β suppression)" is the work of blocking microcalcification from piling up further, "removal" is the work of directly clearing away the pile of stones itself that has already accumulated. For this advanced removal technology to fully establish itself as actual hospital treatment, three basic conditions are needed. The first is "imaging technology" that accurately finds the invisible pile of stones in the blood vessels; the second is "therapeutic medicine" that dissolves the pile of stones or blocks it from clumping further; and the third is "targeted-delivery technology" that helps the medicine hit exactly and only where the microcalcification is, leaving the healthy places alone.
First, the precise imaging technology that finds microcalcification has already entered the actual medical field. "Special PET/CT using a fluorine isotope (18F-NaF PET/CT)" is precisely that core technology. Ordinary CT examination can find only stones of a somewhat large bulk, but this special imaging accurately points out, without surgery or incision, even the invisible microcalcification that is just growing very minutely. It is a principle that uses the property by which a special substance sticks tightly to the main component of the pile of stones in the blood vessels. Through a study published in the renowned journal Nature Communications by a University of Cambridge research team, it was confirmed that this technology can be used on patients. At last, an advanced imaging device has risen to the stage of directly confirming the true cause of the disease with the eyes.
Second, the therapeutic medicine that dissolves stones in the blood vessels or blocks them from growing larger is also right before the actual treatment of patients. The new-drug substance taken by injection (SNF472) is representative. This medicine directly blocks the bone component that makes up microcalcification from being made at all or from hardening further. Looking at a study published in the medical journal Circulation, it succeeded in clearly slowing the speed at which stones pile up in the heart's blood vessels of end-stage renal failure patients, and it is currently in the Phase 3 clinical trial, the last gateway of new-drug development. In another study, a startling result was also published that when a commonly used powerful cholesterol medicine (rosuvastatin) was used for six months, the activity of microcalcification in the blood vessels seen by special imaging clearly subsided.
Third, the targeted-delivery technology that shoots medicine only to the desired place is currently, at the animal-experiment stage, showing results in which the pile of stones in the blood vessels noticeably decreases, and is steadily preparing for human clinical trials. It is an advanced technology specially designed so that a special component that dissolves stones (EDTA) is contained in a very minute micro-capsule (nanoparticle) and then sticks like a magnet only to the blood-vessel wall that has been wounded and worn. When these micro-capsules are put in by injection, they stick only to the wounded site and, for five days, gradually spray out the medicine that dissolves stones. The astonishing effect of dissolving only the microcalcification in the blood vessels, selectively, without touching the healthy blood vessels at all, was proven in animal experiments. According to a study published in a related journal, when this injection was given five times to an animal whose kidney function was ruined, the stones in the blood vessels clearly decreased, and even the body's wrong signal that was about to make stones in the wrong place subsided quietly.
When these three technologies clump perfectly into one, "removal" technology finally stands tall as the hospital's official standard treatment method. Advanced imaging finds the root of the disease, therapeutic medicine breaks the microcalcification, and targeted technology delivers the medicine safely to the exact location. Now, when these three advanced technologies are entering the actual hospital one after another beyond the laboratory, we are witnessing the heart-swelling moment when the "Age of Physical Medicine," which directly and physically resolves the flow and blockage inside the body, approaches beyond mere theory as the dazzling healing of reality.
But until these astonishing treatment methods fully establish themselves in the hospital examination room, the center of gravity of true recovery must still be placed on the Stage 1 "correcting of bad habits" and the thorough "defense" that blocks further accumulation. With only the effort of slowing the piling up of a bad environment in the body and tightly blocking microcalcification from forming further in the blood vessels, half of recovery is already completed. We must raise this firm defensive wall and hopefully prepare and wait for the day when advanced "removal" technology perfectly approaches us.
Even before the hospital's advanced treatment is completed, there is one more very important thing that the patient can start themselves in daily life this very day. Even if we cannot break the pile of stones in the blood vessels right now without surgery, it is the work of smoothly opening up the very flow of blood in the thin vessels, changing my body into a clear and clean environment where microcalcification can no longer easily pile up. If one revives the flow of the blood vessels by regularly sweating with exercise and abundantly supplies clean oxygen, the speed at which microcalcification piles up slows noticeably, and the vicious cycle in which the body was collapsing on its own also stops. This is a very deep and powerful process of "defense" that blocks microcalcification. The road of perfect "removal" that cleanly clears away the already-hardened stones will finally open wide at the point when the hospital's advanced medicines and treatment methods fully arrive at our side.
Figure 6 organizes easily, so that it can be seen at a glance, the three conditions of "removal" that clear away microcalcification in the blood vessels and up to what stage the advanced technologies have currently developed. You can clearly confirm where in the world the three powerful weapons of imaging, medicine, and targeted delivery have come to, and where the domain of defense is that the patient can resolve to start in daily life this very day.
[Figure 6] The Three Basic Conditions of γ Removal: Imaging, Decomposition, Targeting
| Category | Core technology | Degree of completion |
|---|---|---|
| Precise imaging | 18F-NaF PET/CT special isotope imaging technique | Applicable to actual patients (accurately finds even very minute, invisible calcification) |
| 2. Therapeutic medicine | SNF472 calcification-suppressing intravenous injection | In progress in the final stage of clinical trials (Phase 3) |
| Auxiliary | Rosuvastatin, a high-intensity powerful cholesterol medicine | Six-month decrease of microcalcification activity |
| 3. Targeted delivery | EDTA-elastin nanoparticle, a micro-capsule technology that dissolves calcification | Animal-experiment success (proven effect of clearly decreasing calcification in wounded blood vessels) |
| Overall | The three advanced technologies are being prepared for simultaneous introduction into the actual treatment field | Combined, like a multiplication, with the patient's own "defense (β suppression)" effort of blocking the blood vessels, it achieves true recovery |
Recovery Is β × γ: Recovery as Multiplication
Earlier we examined the factors that decide the fork of health and the two recovery efforts. Here one fact becomes very clear. It is the point that true recovery is the multiplication of "defense, which blocks further accumulation," and "removal, which clears away what has already accumulated." Just as the catastrophe of multiplication occurred when the disease arose and the blood vessels and signal were blocked simultaneously, the process of recovering health also operates by a thorough principle of multiplication. The physical law that applies to all things in the cosmos applies just the same to the recovery process of our body.
Making an effort at only one of the two cannot reach true recovery. If one only raises the defensive wall, one can block new microcalcification from piling up, but the pile of stones already embedded in the blood vessels remains as it is and keeps ruining the body. Conversely, if one only clears away the piled-up microcalcification, it becomes clean for the moment, but since the root cause that calls forth the disease remains as it is, microcalcification soon piles up again. Only when the defense that blocks microcalcification from piling up and the removal that clears away piled-up microcalcification interlock and turn simultaneously, like gears, can one finally enter the road of full recovery. This "principle of multiplication" is precisely the deepest and most decisive key that divides health and disease.
The health that patient A obtained five years later is precisely the result of this multiplication operating splendidly. Exercise, a healthy diet, and deep-sleep habits harmonized to firmly accomplish the most important "first-priority defense (correcting bad habits)" and "second-priority defense (stabilizing calcium in the blood)." Moreover, as the flow of blood was opened up by steady exercise, they even made a clear environment where microcalcification could no longer pile up. Although they did not receive the direct "removal" treatment of breaking stones with the hospital's advanced technology, fortunately patient A started management in the early period when blood-vessel blockage was just beginning. In such a shallow state where the disease is not deep, thorough defense alone blocks microcalcification from piling up further, and a natural recovery in which the body clears away its own garbage occurs. As a result, even after five years passed, they could keep their health without a new disease arising.
The heartbreaking situation patient B faced five years later is also a result that this multiplication created. The blood-pressure medicine suppressed the surface figure, but the patient's own effort of "defense" that blocks microcalcification or "removal" that clears it away had both stopped. Since the two numbers of the multiplication were both close to 0, the result too could only stay at 0, and in the end it bore the fearful result of five new diseases and five pills. The medicine only hid the symptoms revealed on the surface; it gave no effect at all to the multiplication of true recovery that pulls out the root of the disease.
For the mother who has continued a long and weary fight against illness, this principle of multiplication operates just the same. If the mother in her late sixties practices the "first-priority defense (exercise, diet, sleep)" and the "second-priority defense (taking good-quality calcium)" this very day, and starts together the natural "removal (regular exercise and clean oxygen)" effort of daily life that opens up the blood vessels, the multiplication of recovery will at last begin to turn powerfully inside the mother's body too. If, on top of this, the hospital's advanced treatment technologies that directly clear away the stones in the blood vessels are introduced into the actual examination room, the speed and depth of recovery will become even more astonishing. The new timetable of health that the mother will walk from here is contained precisely within this multiplication formula. In the following chapter we will unravel in detail how this multiplication of recovery is specifically applied to the treatment of various chronic diseases.
References
[1] Hutcheson, J. D., Maldonado, N., & Aikawa, E. (2014). Small entities with large impact: microcalcifications and atherosclerotic plaque vulnerability. Current Opinion in Lipidology, 25(5), 327-332.
[2] Demer, L. L., & Tintut, Y. (2008). Vascular calcification: pathobiology of a multifaceted disease. Circulation, 117(22), 2938-2948.
[3] Reynolds, J. L., Joannides, A. J., Skepper, J. N., McNair, R., Schurgers, L. J., Proudfoot, D., Jahnen-Dechent, W., Weissberg, P. L., & Shanahan, C. M. (2004). Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. Journal of the American Society of Nephrology, 15(11), 2857-2867.
[4] Klabunde, R. E. (2012). Cardiovascular physiology concepts (2nd ed.). Lippincott Williams & Wilkins.
[5] Iadecola, C. (2017). The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease. Neuron, 96(1), 17-42.
[6] Mitchell, G. F., Hwang, S. J., Vasan, R. S., Larson, M. G., Pencina, M. J., Hamburg, N. M., Vita, J. A., Levy, D., & Benjamin, E. J. (2010). Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation, 121(4), 505-511.
[7] Nigwekar, S. U., Thadhani, R., & Brandenburg, V. M. (2018). Calciphylaxis. New England Journal of Medicine, 378(18), 1704-1714.
[8] Lear, S. A., Hu, W., Rangarajan, S., Gasevic, D., Leong, D., Iqbal, R., et al. (2017). The effect of physical activity on mortality and cardiovascular disease in 130,000 people from 17 high-income, middle-income, and low-income countries: the PURE study. Lancet, 390(10113), 2643-2654.
[9] Irkle, A., Vesey, A. T., Lewis, D. Y., Skepper, J. N., Bird, J. L., Dweck, M. R., Joshi, F. R., Gallagher, F. A., Warburton, E. A., Bennett, M. R., Brindle, K. M., Newby, D. E., Rudd, J. H., & Davenport, A. P. (2015). Identifying active vascular microcalcification by 18F-sodium fluoride positron emission tomography. Nature Communications, 6, 7495.
[10] Raggi, P., Bellasi, A., Bushinsky, D., Bover, J., Rodriguez, M., Ketteler, M., Sinha, S., Salcedo, C., Gillotti, K., Padgett, C., Garg, R., Gold, A., Perelló, J., & Chertow, G. M. (2020). Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis: Results of a Randomized Phase 2b Study. Circulation, 141(9), 728-739.
[11] Oliveira-Santos, M., Borges-Rosa, J., Silva, R., Paixão, L., Espírito Santo, C., Abrunhosa, A., Castelo-Branco, M., Slomka, P. J., Gonçalves, L., & Ferreira, M. J. (2024). Rosuvastatin effect on atherosclerotic plaque metabolism: A subclinical atherosclerosis imaging study with 18F-NaF PET-CT. Atherosclerosis, 395, 117481.
[12] Lei, Y., Nosoudi, N., & Vyavahare, N. (2014). Targeted chelation therapy with EDTA-loaded albumin nanoparticles regresses arterial calcification without causing systemic side effects. Journal of Controlled Release, 196, 79-86.